These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30579177)

  • 1. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
    Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
    Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
    Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
    Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterising phospholipids and free fatty acids in patients with schizophrenia: A case-control study.
    Wang D; Sun X; Maziade M; Mao W; Zhang C; Wang J; Cao B
    World J Biol Psychiatry; 2021 Mar; 22(3):161-174. PubMed ID: 32677491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of eicosanoids and related mediators in patients with schizophrenia.
    Wang D; Sun X; Yan J; Ren B; Cao B; Lu Q; Liu Y; Zeng J; Huang N; Xie Q; Gu H; Wang J
    J Psychiatr Res; 2018 Jul; 102():168-178. PubMed ID: 29674269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous profiling of lysophospholipids and phospholipids from human plasma by nanoflow liquid chromatography-tandem mass spectrometry.
    Lee JY; Min HK; Moon MH
    Anal Bioanal Chem; 2011 Jul; 400(9):2953-61. PubMed ID: 21499968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study.
    Du Y; Chen L; Li XS; Li XL; Xu XD; Tai SB; Yang GL; Tang Q; Liu H; Liu SH; Zhang SY; Cheng Y
    Schizophr Bull; 2021 Apr; 47(3):615-623. PubMed ID: 33159208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
    Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
    J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics and lipidomics analyses by
    Tasic L; Pontes JGM; Carvalho MS; Cruz G; Dal Mas C; Sethi S; Pedrini M; Rizzo LB; Zeni-Graiff M; Asevedo E; Lacerda ALT; Bressan RA; Poppi RJ; Brietzke E; Hayashi MAF
    Schizophr Res; 2017 Jul; 185():182-189. PubMed ID: 28040324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics.
    Su Q; Bi F; Yang S; Yan H; Sun X; Wang J; Qiu Y; Li M; Li S; Li J
    Psychiatry Investig; 2023 Sep; 20(9):818-825. PubMed ID: 37794663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes as potential masking agents in sport doping. Part 1: analysis of phospholipids and sphingomyelins in drugs and biological fluids by aqueous normal-phase liquid chromatography-tandem mass spectrometry.
    Esposito S; Colicchia S; de la Torre X; Mazzarino M; Botrè F
    Drug Test Anal; 2017 Jan; 9(1):75-86. PubMed ID: 26857656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Membrane Lipid Homeostasis in Schizophrenia.
    Li M; Gao Y; Wang D; Hu X; Jiang J; Qing Y; Yang X; Cui G; Wang P; Zhang J; Sun L; Wan C
    Schizophr Bull; 2022 Sep; 48(5):1125-1135. PubMed ID: 35751100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
    Song M; Liu Y; Zhou J; Shi H; Su X; Shao M; Yang Y; Wang X; Zhao J; Guo D; Liu Q; Zhang L; Zhang Y; Lv L; Li W
    Psychiatry Res; 2023 Mar; 321():115070. PubMed ID: 36706560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
    Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
    Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and Reliable Identification of Phospholipids for Untargeted Metabolomics with LC-ESI-QTOF-MS/MS.
    Godzien J; Ciborowski M; Martínez-Alcázar MP; Samczuk P; Kretowski A; Barbas C
    J Proteome Res; 2015 Aug; 14(8):3204-16. PubMed ID: 26080858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
    Lindahl A; Forshed J; Nordström A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipidomic identification of potential serum biomarkers in dengue fever, hepatitis B and hepatitis C using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Khedr A; Hegazy MA; Kammoun AK; Shehata MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():44-54. PubMed ID: 26708624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid.
    Cicalini I; Rossi C; Pieragostino D; Agnifili L; Mastropasqua L; di Ioia M; De Luca G; Onofrj M; Federici L; Del Boccio P
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
    Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
    Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
    Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
    J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.